SCHEMBL8535967

SCHEMBL8535967

CCOC(=O)CCCC1(C(=O)OCC)CCc2ccccc2C1=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 1/20 0.43
CYP4F2 P78329 1/20 0.41
CYP4A11 Q02928 1/20 0.41
NAMPT P43490 1/20 0.41
ALDH1A1 P00352 3/20 0.40
NOTUM Q6P988 1/20 0.40
GAA P10253 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.39
KDM4E B2RXH2 1/20 0.38
HPGD P15428 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
GPR119 Q8TDV5 3/20 0.38
HTR2A P28223 2/20 0.38
HTR2C P28335 2/20 0.38
HTR2B P41595 2/20 0.38
SIGMAR1 Q99720 2/20 0.38
LMNA P02545 1/20 0.38
OPRM1 P35372 2/20 0.38
SLC22A1 O15245 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9344111 0.93 ALDH1A1 (0.42) BRD4CYP4F2CYP4A11NAMPTALDH1A1
SCHEMBL22692122 0.91 BRD4 (0.39) BRD4CYP4F2CYP4A11NAMPTALDH1A1
SCHEMBL29423722 0.91 BRD4 (0.39) BRD4CYP4F2CYP4A11NAMPTALDH1A1
SCHEMBL9505686 0.87 OPRM1 (0.41) ALDH1A1SMN1; SMN2KDM4EHPGDTDP1
SCHEMBL13998334 0.87 SMN1; SMN2 (0.40) BRD4ALDH1A1NOTUMGAASMN1; SMN2
SCHEMBL9344178 0.87 ALDH1A1 (0.42) BRD4ALDH1A1NOTUMGAASMN1; SMN2
SCHEMBL29423728 0.84 MAPT (0.38) BRD4NAMPTALDH1A1NOTUMGAA
SCHEMBL22692132 0.84 MAPT (0.38) BRD4NAMPTALDH1A1NOTUMGAA
SCHEMBL7163925 0.82 NAMPT (0.44) BRD4CYP4F2CYP4A11NAMPTALDH1A1
SCHEMBL22709340 0.79 BRD4 (0.41) BRD4CYP4F2CYP4A11NAMPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5847159-A 1- ω-(3,4-dihydro-2-naphthalenyl)alkyl!-cyclic amine derivatives, process for preparing the same, and pharmaceutical composition containing the same DAINIPPON PHARMACEUTICAL CO., LTD. (JP) 1998-12-08 US disclosed
EP-0825180-A1 1-OMEGA-(3,4-DIHYDRO-2-NAPHTHALENYL)ALKYL] CYCLIC AMINE DERIVATIVES, PROCESS FOR PRODUCING THE SAME, AND MEDICINAL COMPOSITION CONTAINING THE SAME DAINIPPON PHARMACEUTICAL CO., LTD. (JP) 1998-02-25 EP disclosed
US-5292768-A Compound effective as cerebral insufficiency improver SUNTORY LIMITED (JP) 1994-03-08 US disclosed
US-5288752-A Brain disorders SUNTORY LIMITED (JP) 1994-02-22 US disclosed
EP-0322248-B1 COMPOUNDS EFFECTIVE AGAINST CEREBRAL INSUFFICIENCY SUNTORY LIMITED (JP) 1993-08-04 EP disclosed
US-5179092-A Cognition activators SUNTORY LIMITED (JP) 1993-01-12 US disclosed
US-5057514-A Compounds effective as cerebral schemia treating agents SUNTORY LIMITED (JP) 1991-10-15 US disclosed